KZA 0.00% 8.0¢ kazia therapeutics limited

Ann: Appendix 4C - quarterly, page-2

  1. 375 Posts.
    lightbulb Created with Sketch. 120
    December quarter saw the outflow of a prepayment of USD5m for the start of the GBM Agile trial, as well as significant start up expenses associated with that trial. Adjusting only for the deposit, the cash outflow would have been approx. AUD7m lower and the cash balance approx. AUD7m higher, yielding a result of 7 quarters of cash available.

 
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.